← Back to Search

Fibroscan for Cystic Fibrosis

N/A

Waitlist Available

Led By Mary C. Drinane, MD

Research Sponsored by Dartmouth-Hitchcock Medical Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up visit 1, day 1

Awards & highlights

Study Summary

This trial will explore if there is a link between developing impaired glucose tolerance, the characteristics of CFLD, and the likelihood of liver fibrosis.

Eligible Conditions

Diabetes-Related Cystic Fibrosis
Cystic Fibrosis Liver Disease
Cystic Fibrosis

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ visit 1, day 1

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~visit 1, day 1

This trial's timeline: 3 weeks for screening, Varies for treatment, and visit 1, day 1 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Assess CFLD via abdominal imaging

Assess Hepatic Function of CFLD

Assess Oral Glucose of CFLD

+2 more

Trial Design

1Treatment groups

Experimental Treatment

Group I: FibroscanExperimental Treatment1 Intervention

One study visit for fibroscan measurement of the liver.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Fibroscan

2016

N/A

~1100

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Dartmouth-Hitchcock Medical CenterLead Sponsor

524 Previous Clinical Trials

2,543,339 Total Patients Enrolled

9 Trials studying Cystic Fibrosis

2,289 Patients Enrolled for Cystic Fibrosis

Trustees of Dartmouth CollegeOTHER

23 Previous Clinical Trials

10,685 Total Patients Enrolled

Mary C. Drinane, MDPrincipal InvestigatorDartmouth-Hitchcock Medical Center

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many individuals are engaged in this research endeavor?

"Confirmed. As per information from clinicaltrials.gov, this research is presently recruiting participants and was initially posted on March 31st 2022 with a subsequent edit later that same day. There are 30 patients being sought out at one site for enrolment in the trial."

Answered by AI

Are new participants being sought for this research endeavor?

"This investigation, which was initially published on March 31st 2022 and has since been renovated, is recruiting patients as confirmed by clinicaltrials.gov."

Answered by AI

Recent research and studies

Frontiers in EndocrinologyJournal

Cystic Fibrosis-related Diabetes

Kayani, Kayani, Raihan Mohammed, and Hasan Mohiaddin. 2018. “Cystic Fibrosis-related Diabetes”. Frontiers in Endocrinology. Frontiers Media SA. doi:10.3389/fendo.2018.00020.

GastroenterologyJournal

Insulin Resistance Is Associated with Chronic Hepatitis C and Virus Infection Fibrosis Progression

Hui, Jason M, Archana Sud, Geoffrey C Farrell, Priyanka Bandara, Karen Byth, James G Kench, Geoffrey W McCaughan, and Jacob George. 2003. “Insulin Resistance Is Associated with Chronic Hepatitis C and Virus Infection Fibrosis Progression”. Gastroenterology. Elsevier BV. doi:10.1053/j.gastro.2003.08.032.

Nature MedicineJournal

Mechanisms of NAFLD Development and Therapeutic Strategies

Friedman, Scott L., Brent A. Neuschwander-Tetri, Mary Rinella, and Arun J. Sanyal. 2018. “Mechanisms of NAFLD Development and Therapeutic Strategies”. Nature Medicine. Springer Science and Business Media LLC. doi:10.1038/s41591-018-0104-9.

Plos OneJournal